top of page
Search

End-of-Life Care: Syringe Drivers & Medications (MRCP Part 1)

TL;DR:

Syringe drivers are used in the last days of life to deliver continuous symptom-relief when oral medication is no longer possible. For MRCP Part 1, you must know when to start one, which drugs are appropriate, key dose principles (especially in renal failure), and common exam traps.


Why this topic matters for MRCP Part 1

End-of-life care is frequently tested because it brings together prescribing safety, ethics, and clinical judgement. MRCP questions rarely expect specialist palliative knowledge; instead, they focus on principles: recognising dying, prioritising comfort, choosing appropriate medications, and avoiding unnecessary or harmful interventions.

Most exam stems describe a patient with advanced malignancy or end-stage organ failure who is no longer able to swallow, is distressed, breathless, or agitated. The correct answer usually involves timely initiation of a syringe driver with appropriate anticipatory medications.


What is a syringe driver?

A syringe driver (also called a continuous subcutaneous infusion, CSCI) delivers medication steadily over 24 hours via the subcutaneous route.

Core principles (high-yield):

  • Used when the oral route is no longer reliable

  • Aims to relieve symptoms, not prolong life

  • Requires regular review and titration

  • Does not replace PRN (breakthrough) medication

Exam pearl: Starting a syringe driver is not “giving up”; failing to control symptoms is poor care.

Indications: when to start a syringe driver

For MRCP Part 1, the common indications are:

  • Inability to swallow tablets or liquids

  • Persistent vomiting

  • Reduced level of consciousness

  • Poor symptom control despite regular oral medication

  • Last days of life with fluctuating symptoms

Important trap: Do not start a syringe driver solely because a patient is dying if symptoms are well controlled orally.


Common medications used in syringe drivers

You are expected to recognise first-line drugs and their indications, not memorise complex regimens.

Symptom

Common drug

Exam focus

Pain

Morphine (or alternative opioid)

Reduce dose in renal failure

Breathlessness

Opioid ± midazolam

Opioids relieve dyspnoea

Agitation / terminal restlessness

Midazolam

Short-acting benzodiazepine

Respiratory secretions (“death rattle”)

Glycopyrronium or hyoscine butylbromide

Antimuscarinic drugs

Nausea / vomiting

Haloperidol or levomepromazine

Choose based on cause

Renal failure: Morphine metabolites accumulate → dose reduction or alternative opioid may be needed. This is a classic MRCP question.


MRCP Part 1 revision on end-of-life care and syringe driver medications

The 5 most tested subtopics

  1. Recognising the dying phase Reduced oral intake, drowsiness, terminal secretions.

  2. Opioids for breathlessness Low-dose opioids relieve dyspnoea even without pain.

  3. Terminal agitation Midazolam is first-line; avoid excessive sedation without review.

  4. Management of secretions Antimuscarinics reduce noise; suction and antibiotics are ineffective.

  5. Anticipatory prescribing Prescribe before symptoms become severe.


Mini-case (MRCP style)

Case: A 79-year-old woman with metastatic breast cancer is bed-bound, drowsy, and unable to swallow. She is breathless at rest, agitated overnight, and has noisy respiratory secretions. Oral morphine was stopped yesterday.

Question: What is the most appropriate management?

Answer: Start a syringe driver with an opioid (dose adjusted if renal impairment), midazolam for agitation, and an antimuscarinic for secretions, plus PRN breakthrough doses.

Why this is correct: She is in the last days of life, cannot take oral medication, and has multiple uncontrolled symptoms. Oxygen or antibiotics would not address comfort.


Five common exam traps

  • Escalating oxygen instead of treating dyspnoea pharmacologically

  • Using full-dose morphine in advanced renal failure

  • Withholding opioids due to fear of respiratory depression

  • Treating terminal secretions with antibiotics

  • Forgetting PRN breakthrough prescriptions


Practical revision checklist

Before the exam, make sure you can answer “yes” to all of these:

  • Can I list clear indications for a syringe driver?

  • Do I know first-line drugs for pain, agitation, and secretions?

  • Can I adjust opioids in renal impairment?

  • Do I remember that PRN meds are still required?

  • Can I spot over-treatment vs under-treatment in end-of-life stems?

Practise this topic with exam-style questions in the Crack Medicine MRCP Part 1 Question Bank:https://www.crackmedicine.com/qbank/

For exam-day readiness, complete a timed paper here:https://www.crackmedicine.com/mock-tests/


FAQs

When should a syringe driver be started at end of life?

When the oral route is no longer possible or symptoms are poorly controlled, particularly in the last days of life.

Which drugs are most commonly used in syringe drivers?

An opioid for pain or dyspnoea, midazolam for agitation, and an antimuscarinic for secretions.

Is morphine always appropriate?

No. Dose reduction or alternative opioids are needed in renal failure.

Do syringe drivers replace PRN medication?

No. Breakthrough PRN drugs should always be prescribed.


Ready to start?

Ready to lock this topic in for the exam?

👉 Revise smarter for MRCP Part 1 by pairing this article with high-yield MCQs and timed practice:


Sources

 
 
 

Comments

bottom of page